THRX-165724

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTHRX-165724
Drug Alias NameTHRX-165724AMI-10706
ClassificationSmall molecules
Mechanisms of ActionAnticancer protein kinase inhibitorsTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnoviva Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnoviva Inc
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A